1. Development of a Novel Anti-Mouse CCR2 Monoclonal Antibody (C2Mab-6) by N-Terminal Peptide Immunization
   Tomohiro Tanaka et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
2. Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
   Guanjie Li et al, 2022, Antibodies CrossRef
3. TrMab-6 Exerts Antitumor Activity in Mouse Xenograft Models of Breast Cancers
   Tomohiro Tanaka et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
4. Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7) by N-terminal Peptide Immunization
   Teizo Asano et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
5. TgMab-2: An Anti-human T Cell Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domain Monoclonal Antibody for Immunocytochemistry
   Masaki Saito et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
6. Targeting Breast Cancer: An Overlook on Current Strategies
   Domenico Iacopetta et al, 2023, International Journal of Molecular Sciences CrossRef
7. PMab-301: An Anti-Giraffe Podoplanin Monoclonal Antibody for Immunohistochemistry
   Tsunenori Ouchida et al, 2023, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
8. KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry
   Masaki Saito et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
9. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C9Mab-11) by N-Terminal Peptide Immunization
   Tomohiro Tanaka et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
10. C3Mab-3: A Monoclonal Antibody for Mouse CC Chemokine Receptor 3 for Flow Cytometry
    Teizo Asano et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
11. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers
    Ren Nanamiya et al, 2023, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
12. Clinical development of antibody-drug conjugates in triple negative breast cancer: can we jump higher?
    Dimitrios Zardavas, 2022, Expert Opinion on Investigational Drugs CrossRef
13. Comparative expression of trophoblast cell-surface antigen 2 (TROP2) in the different molecular subtypes of invasive breast carcinoma: An immunohistochemical study of 94 therapy-naive primary breast tumors
    Richard B. Mertens et al, 2024, Annals of Diagnostic Pathology CrossRef
14. Development of an Anti-human CCR2 Monoclonal Antibody (C2Mab-9) by N-Terminal Peptide Immunization
    Tomohiro Tanaka et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
15. Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning
    Yuki Okada et al, 2024, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
16. Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
    Paolo Tarantino et al, 2022, CA: A Cancer Journal for Clinicians CrossRef
17. Targeting Trop2 in solid tumors: a look into structures and novel epitopes
    Xinlin Liu et al, 2023, Frontiers in Immunology CrossRef
18. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma
    Teizo Asano et al, 2021, Oncology Reports CrossRef
19. Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C6Mab-13) by N-Terminal Peptide Immunization
    Teizo Asano et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef